Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Aslan Pharmaceuticals Ltd ADR

ASLN
Current price
0.51 USD +0.005 USD (+1.00%)
Last closed 0.5 USD
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 10 503 675 USD
Yield for 12 month +9.07 %
Week
Month
Year
ASLN
21.11.2021 - 28.11.2021

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal antibody that targets the IL-13 receptor a1 subunit which is being developed for the treatment of atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune diseases. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore. Address: 83 Clemenceau Avenue, Singapore, Singapore, 239920

Analytics

WallStreet Target Price

16 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

+383 889 USD

Current Year

Last Year

Current Quarter

Last Quarter

+383 889 USD

Key Figures ASLN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -44 130 628 USD
Operating Margin TTM -367.97 %
PE Ratio
Return On Assets TTM -40.64 %
PEG Ratio
Return On Equity TTM -237.75 %
Wall Street Target Price 16 USD
Revenue TTM 12 000 000 USD
Book Value 0.38 USD
Revenue Per Share TTM 0.81 USD
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM 79 821 000 USD
Earnings Share -2.96 USD
Diluted Eps TTM -2.96 USD
Most Recent Quarter III 2023
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ASLN

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ASLN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor 1:5
Payout Ratio
Last Split Date 13.03.2023
Dividend Date

Stock Valuation ASLN

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 0.6698
Price Sales TTM 0.8753
Enterprise Value EBITDA -0.1965
Price Book MRQ 2.1426

Financials ASLN

1 year
3 years
5 years
10 years
Results 2019 Dynamics

Technical indicators ASLN

For 52 weeks

0.63 USD 4.69 USD
50 Day MA 1.23 USD
Shares Short Prior Month 34 942
200 Day MA 2.68 USD
Short Ratio 2.36
Shares Short 42 194
Short Percent 0.3 %